SynthesisActa haematologica2019

Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.

Zhichao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.